-
2
-
-
0023103540
-
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH
-
Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987;82:192-9.
-
(1987)
Am J Gastroenterol
, vol.82
, pp. 192-199
-
-
Morris, A.1
Nicholson, G.2
-
3
-
-
0023688188
-
Iatrogenic Campylobacter pylori infection as a cause of epidemic achlorhydria
-
Graham Y, Alpert LC, Smith JL, Yoshimura HH. Iatrogenic Campylobacter pylori infection as a cause of epidemic achlorhydria. Am J Gastroenterol 1988;83:974-80.
-
(1988)
Am J Gastroenterol
, vol.83
, pp. 974-980
-
-
Graham, Y.1
Alpert, L.C.2
Smith, J.L.3
Yoshimura, H.H.4
-
4
-
-
25844490055
-
Treatment of Helicobacter pylori
-
Bytzer P, O'Morain C. Treatment of Helicobacter pylori, Helicobacter,2010;10:40-46.
-
(2010)
Helicobacter
, vol.10
, pp. 40-46
-
-
Bytzer, P.1
O'Morain, C.2
-
5
-
-
0029130891
-
Selective adherence of a sucralfate-tetracycline complex to gastric ulcers: Implications for the treatment of Helicobacter pylori
-
Yokel RA, Dicke KM, Goldberg AH. Selective adherence of a sucralfate-tetracycline complex to gastric ulcers: implications for the treatment of Helicobacter pylori. Biopharm Drug Dispos 1995; 16: 475-479.
-
(1995)
Biopharm Drug Dispos
, vol.16
, pp. 475-479
-
-
Yokel, R.A.1
Dicke, K.M.2
Goldberg, A.H.3
-
6
-
-
0032768423
-
Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection
-
Shah S, Qaqish R, Patel V, Amiji M. Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection. J Pharm Pharmacol. 1999;51: 667-672.
-
(1999)
J Pharm Pharmacol
, vol.51
, pp. 667-672
-
-
Shah, S.1
Qaqish, R.2
Patel, V.3
Amiji, M.4
-
7
-
-
0037436923
-
Bioadhesive microspheres as a controlled drug delivery system
-
Vasir AK, Tambwekar K and Garg S. Bioadhesive microspheres as a controlled drug delivery system. Intl J Pharm 2003;14:13-32.
-
(2003)
Intl J Pharm
, vol.14
, pp. 13-32
-
-
Vasir, A.K.1
Tambwekar, K.2
Garg, S.3
-
8
-
-
57349178623
-
In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin
-
Zhepeng L, Weiyue L, Lisheng Q, Xuhui Z. In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin. J Control Rel 2004;81:327-34.
-
(2004)
J Control Rel
, vol.81
, pp. 327-334
-
-
Zhepeng, L.1
Weiyue, L.2
Lisheng, Q.3
Xuhui, Z.4
-
9
-
-
0031048495
-
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice:Relevance to the treatment of Helicobacter pylori infection
-
Erah PO, Goddard AF, Barrett D, Shaw PN, Spiller RC, The stability of amoxycillin, clarithromycin and metronidazole in gastric juice:relevance to the treatment of Helicobacter pylori infection, J Antimicrob Chemother. 1997;39:5-12.
-
(1997)
J Antimicrob Chemother
, vol.39
, pp. 5-12
-
-
Erah, P.O.1
Goddard, A.F.2
Barrett, D.3
Shaw, P.N.4
Spiller, R.C.5
-
10
-
-
0026508584
-
Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin
-
Nakagawa Y, Itai S, Yoshida T, Nagai T. Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin, Chem Pharm Bull 1992;40:725-728.
-
(1992)
Chem Pharm Bull
, vol.40
, pp. 725-728
-
-
Nakagawa, Y.1
Itai, S.2
Yoshida, T.3
Nagai, T.4
-
11
-
-
1842486782
-
Development and characterization of Mucoadhesive Microspheres Bearing Salbutamol for Nasal Delivery
-
Jain SK, Chourasia MK, Jain AK. Jain RK. Development and characterization of Mucoadhesive Microspheres Bearing Salbutamol for Nasal Delivery, Drug Deliv 2004;11:113-22.
-
(2004)
Drug Deliv
, vol.11
, pp. 113-122
-
-
Jain, S.K.1
Chourasia, M.K.2
Jain, A.K.3
Jain, R.K.4
-
12
-
-
67650635130
-
Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability
-
Tao Y, Lu Y, Sun Y, Gu B, Lu W, Pan J. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability. Int J Pharm 2009;3:30-36.
-
(2009)
Int J Pharm
, vol.3
, pp. 30-36
-
-
Tao, Y.1
Lu, Y.2
Sun, Y.3
Gu, B.4
Lu, W.5
Pan, J.6
|